Dr Roy Kong

Biography

Roy has extensive expertise in receptor mechanics and pre-clinical testing of novel pharmaceutical compounds. He specialises in using various in vitro and in vivo systems to characterise the behavior of novel compounds and their respective receptors. Prior to OccuRx, Roy worked with the team at Fibrotech Therapeutics, where he investigated the molecular mechanisms of FT011. Concurrent to his role with OccuRx, Roy is also a Research Fellow at the Biomedical Translational Research Group at the Department of Medicine, the University of Melbourne. Roy completed his scientific training in 2012 at the Florey Institute of Neuroscience and Mental Health, Melbourne where he dissected the activation of a unique class of receptors that is emerging as a significant therapeutic target. His project earned him multiple publications, presenting opportunities at conferences and awards.

Research Interest

  Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management